BFA
RVMD icon

Beaumont Financial Advisors’s Revolution Medicines RVMD Stock Holding History

Beaumont Financial Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Sell
2,985
-6,815
-70% -$995K 0.04% 235
2026
Q1 		$953K Sell
9,800
-720
-7% -$72.7K 0.07% 169
2025
Q4 		$838K Hold
10,520
– – 0.06% 173
2025
Q3 		$491K Sell
10,520
-3,204
-23% -$125K 0.03% 243
2025
Q2 		$505K Hold
13,724
– – 0.04% 219
2025
Q1 		$485K Sell
13,724
-14
-0.1% -$568 0.04% 225
2024
Q4 		$601K Sell
13,738
-1,186
-8% -$59.9K 0.05% 204
2024
Q3 		$677K Hold
14,924
– – 0.05% 181
2024
Q2 		$579K Hold
14,924
– – 0.05% 198
2024
Q1 		$481K Hold
14,924
– – 0.04% 207
2023
Q4 		$428K Buy
+14,924
New +$359K 0.04% 215

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Beaumont Financial Advisors's RVMD Position: Q2 2026 in Review

Beaumont Financial Advisors reduced its Revolution Medicines (RVMD) stake by 70% in Q2 2026, selling an estimated $995K and leaving 2,985 shares worth $559K. The position accounts for 0.04% of the portfolio, ranked #235.

Beaumont Financial Advisors first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $953K in Q1 2026. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Beaumont Financial Advisors held 2,985 shares of Revolution Medicines worth $559K as of Q2 2026.
  • Beaumont Financial Advisors sold 6,815 Revolution Medicines shares in Q2 2026, an estimated $995K.
  • Revolution Medicines made up 0.04% of Beaumont Financial Advisors's portfolio in Q2 2026, its #235 holding.
  • Beaumont Financial Advisors first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • Beaumont Financial Advisors's Revolution Medicines position peaked at $953K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Beaumont Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.